In his article, “The Present State of Antineoplaston Research” (2004), Dr. Stanislaw …show more content…
Stanislaw Burzynski has extensively published many of his findings in the medical literature, which includes more than ten- thousand human clinical trials, many of which traces if cancer have completely disappeared. In 1991, a group of researchers from the National Cancer Institute examined seven patient records with cases of brain tumors, many of which were fatal. The team concluded that there were positive responses to five out of the seven treatments, thus providing important independent confirmation for the Burzynski procedure. The only problematic aspect of the treatment is that Burzynski’s treatment is extremely expensive, ranging in costs of around tens of thousands of dollars each year (Brownlee, Cohen 20). Patients also must travel to Dr. Burzynski’s personal clinic in Houston, Texas to receive this treatment as …show more content…
We see great people. We see crooks. We have prostitutes. We have thieves. We have mafia bosses. We have Secret Service agents. Many people are coming to us, OK? Not all of them are the greatest people in the world. And many of them would like to get money from us. They pretend they got sick and they would like to extort money from us." History will vindicate him, Burzynski says, just as it has vindicated other persecuted medical "pioneers," such as Louis Pasteur. In the future, Burzynski says, everyone will use his therapies, and the cancer treatments used today — such as surgery, chemotherapy and radiation — will be regarded as barbaric. "There will be a time when people will see the light," he says, "and our treatments will be used by everyone” (Faulkner 23). Although some proponents of antineoplaston therapy have suggested that the reviews of this treatment by conventional cancer specialists are biased due to the mistrust and disbelief of cancer specialists who have dealt with cancer patients for over forty years, some cancer researchers still have problems with the idea of antineoplaston therapy. According to Andrew Weil from the American Cancer